Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal
  4. Page 2

Federal regulations

Agency
  • DOC231
  • DOT212
SEC
201
  • HHS185
  • FDA159
  • DOE146
  • DHS142
  • FERC130
  • FAA96
  • EPA83
  • NOAA76
  • NIH53
  • DOJ51
  • Treasury50
  • USDA47
  • DOL38
  • FCC25
  • SBA23
  • CMS18
  • IRS18
  • HUD17
  • FTC5
  • Topic
    • Compliance15
    • Finance7
    • Legal4
    • Operations3
    • Tax3
    • Administration1
    • Customer Success1
    • Procurement1
    • Product Development1
    • Supply Chain1
    • + 1 more topics
    • Vendor Management1
    Recency
    • Last 30 days
    • Last 7 days
    NIHRemove filter: NIHTreasuryRemove filter: TreasuryClear all
    • Center for Scientific Review; Amended Notice of Meeting
      June 15, 2026

      Center for Scientific Review amends meeting notice regarding review panels and grant evaluation procedures for National Institutes of Health funding decisions.

    • Government Owned Inventions Available for License: Fluorophthalimides as Anti-Inflammatory Agents for Systemic and Neurodegenerative Disorders
      June 15, 2026

      National Institute on Aging offers licensing opportunities for fluorophthalimide compounds in development as anti-inflammatory therapeutics for systemic and neurodegenerative disorders.

    • Center for Scientific Review; Amended Notice of Meeting
      June 15, 2026

      Center for Scientific Review announces amended open meeting schedule to discuss peer review processes and grant evaluation procedures for National Institutes of Health funding cycles.

    • Government Owned Inventions Available for License: 4-Amino-2-(Piperidin-3-yl)Isoindoline-1,3-Diones as Anti-Inflammatory Agents for Systemic Degenerative and Neurodegenerative Disorders
      June 15, 2026

      National Institute on Aging offers licensing opportunities for 4-amino-2-(piperidin-3-yl)isoindoline-1,3-diones, pre-clinical anti-inflammatory compounds targeting systemic and neurodegenerative disorders, to qualified research and commercialization…

    • Center for Scientific Review; Notice of Closed Meetings
      June 12, 2026

      Center for Scientific Review will hold closed National Institutes of Health peer-review committee meetings to evaluate grant applications and discuss confidential research proposals.

    • Agency Information Collection Activities: Information Collection Revision; Comment Request; Licensing Manual
      June 12, 2026

      The OCC requests public comment on a revised Licensing Manual information collection under Paperwork Reduction Act requirements to reduce respondent burden.

    • Agency Information Collection Activities: Proposed Information Collection; Reporting Forms and Instructions for Permitted Payment Stablecoin Issuers Subject to the Jurisdiction of the Office of the Comptroller of the Currency; Comment Request
      June 12, 2026

      The OCC proposes new weekly and quarterly reporting requirements for permitted payment stablecoin issuers under its jurisdiction and seeks OMB approval for the information collection.

    • Notice of OFAC Sanctions Action
      June 12, 2026

      OFAC adds individuals to the Specially Designated Nationals and Blocked Persons List, requiring U.S. persons to block all property and transactions involving these designated parties.

    • Center for Scientific Review; Notice of Closed Meetings
      June 12, 2026

      Center for Scientific Review will hold closed National Institutes of Health review meetings to evaluate grant applications across multiple scientific disciplines during specified dates in 2024 and 2025.

    • National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting
      June 12, 2026

      National Institute of Biomedical Imaging and Bioengineering announces a public meeting to discuss research funding priorities and grant opportunities for biomedical imaging and bioengineering projects.

    PreviousPage 2 of 11 (103 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Alabama
    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Kentucky
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants